1,130 件 ・ 関連度順
概要と使いどころ
Friendly elementary-school homework tutoring App-in-Skill. Use when the user invokes $kelly-homework-coach or /kelly-homework-coach, mentions 小学生作业辅导, homework photo tutoring, 拍照讲题, 作业答疑, 错题本, error notebook, mistake-book review, practice paper generation, exam paper analysis, parent/teacher review of AI explanations, or wants a child-friendly UI for step-by-step homework help with parent/teacher review and safety boundaries.
日本語の概要は準備中です。原文の説明を表示しています。
Set up Claude Code hooks to block dangerous git commands (push, reset --hard, clean, branch -D, etc.) before they execute. Use when user wants to prevent destructive git operations, add git safety hooks, or block git push/reset in Claude Code.
日本語の概要は準備中です。原文の説明を表示しています。
How to author, edit, and adapt PostHog Signals scouts — the scheduled agents that scan a project and emit findings into the Signals inbox. Use when a user wants to customize a canonical scout for their own setup (narrow its scope, retune its thresholds, add disqualifiers), tweak a scout's schedule or dry-run posture, or write a brand-new scout from scratch for a specific use case (a custom event, a product surface no canonical scout covers). Covers the scout SKILL.md anatomy, the emit contract, the dedupe + scratchpad-memory conventions, the per-team skills-store path vs the canonical in-repo path, and the emit-and-inspect test loop (with dry-run as an optional safety net). Trigger on "write/edit/customize a signals scout", "new scout for X", "tune my scout schedule", "make a scout that watches <event>".
日本語の概要は準備中です。原文の説明を表示しています。
Identify and clean up stale feature flags in a PostHog project. Use when the user wants to find unused, fully rolled out, or abandoned feature flags, review them for safety, and then disable or delete them. Covers staleness detection, dependency checking, and safe removal workflows.
日本語の概要は準備中です。原文の説明を表示しています。
Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.
日本語の概要は準備中です。原文の説明を表示しています。
Select colormaps and qualitative palettes for scientific figures using perceptual-uniformity, color-vision-deficiency safety, and luminance-monotonicity criteria. Covers Crameri scientific colormaps, viridis/cividis/magma, Okabe-Ito categorical, ColorBrewer, and the rainbow/jet critique. Use when choosing palettes for heatmaps, scatter, networks, or any encoding where color carries quantitative or categorical meaning.
日本語の概要は準備中です。原文の説明を表示しています。
Prepares statistical reports for clinical trials following CONSORT 2025, SPIRIT 2025, ICH E9(R1) estimands, and FDA 2023 covariate adjustment guidance. Covers Table 1 generation, analysis populations (ITT/FAS/PP/Safety), the 5 ICH E9(R1) intercurrent-event strategies, MMRM under MAR (mmrm), reference-based MI (rbmi J2R/CR/CIR), Permutt tipping-point sensitivity, and Rubin's-rules vs frequentist variance debate. Use when preparing regulatory submissions, defining estimands, or implementing missing-data sensitivity analyses.
日本語の概要は準備中です。原文の説明を表示しています。
Evaluates LLMs across 100+ benchmarks from 18+ harnesses (MMLU, HumanEval, GSM8K, safety, VLM) with multi-backend execution. Use when needing scalable evaluation on local Docker, Slurm HPC, or cloud platforms. NVIDIA's enterprise-grade platform with container-first architecture for reproducible benchmarking.
日本語の概要は準備中です。原文の説明を表示しています。
Guarantee valid JSON/XML/code structure during generation, use Pydantic models for type-safe outputs, support local models (Transformers, vLLM), and maximize inference speed with Outlines - dottxt.ai's structured generation library
日本語の概要は準備中です。原文の説明を表示しています。
Quantitative drug-target validation pipeline. Scores druggability, selectivity, safety profile, ADMET feasibility, and structural tractability with a composite Target Validation Score (0-100) and GO/NO-GO recommendation. Use for go/no-go decisions on a target before commit-to-medchem, target prioritization across a list, and target-deselection rationale.
日本語の概要は準備中です。原文の説明を表示しています。
Assess drug-drug interactions — CYP metabolic interactions (substrate/inhibitor/inducer), transporter (P-gp, BCRP, OATP) effects, pharmacodynamic synergy/antagonism, clinical significance scoring, and management recommendations. Use for polypharmacy review, prescribing decision support, and safety analysis when adding or switching drugs.
日本語の概要は準備中です。原文の説明を表示しています。
Predicts ADMET properties using ADMETlab 3.0 (119 endpoints with uncertainty), ADMET-AI, DeepChem MolNet, and chemprop D-MPNN with explicit handling of OECD QSAR principles, applicability domain assessment, calibration, hERG/CYP/AMES gold-standard endpoints, and PAINS / Lipinski / Ro5 / Veber / BBB druglikeness filters. Use when filtering compounds for drug-likeness, prioritizing leads by predicted safety, or building an in-house ADMET QSAR model.
日本語の概要は準備中です。原文の説明を表示しています。
Plan adventure tourism experiences with safety. TRIGGERS - Use when user needs help with adventure-tourism-plan related tasks.
日本語の概要は準備中です。原文の説明を表示しています。
Plan aerial photography with permits and safety. TRIGGERS - Use when user needs help with aerial-photography-plan related tasks.
日本語の概要は準備中です。原文の説明を表示しています。
Plan adventure travel with safety and equipment. TRIGGERS - Use when user needs help with adventure-travel-plan related tasks.
日本語の概要は準備中です。原文の説明を表示しています。
Stop AI agents from secretly bypassing your rules. Mechanical enforcement with git hooks, secret detection, deployment verification, and import registries. Born from real production incidents: server crashes, token leaks, code rewrites. Works with Claude Code, Clawdbot, Cursor. Install once, enforce forever.
日本語の概要は準備中です。原文の説明を表示しています。
Evaluates and implements age estimation and verification technologies for online services. Covers facial age estimation, digital ID verification, self-declaration with risk assessment, AI-based age estimation, and the accuracy versus privacy tradeoff. Includes ICO guidance and euCONSENT framework. Keywords: age verification, age estimation, facial analysis, digital ID, children, online safety.
日本語の概要は準備中です。原文の説明を表示しています。
Comprehensive PR code review for OneKey monorepo. Use when reviewing PRs, code changes, or diffs — covers security (secrets/PII leakage, supply-chain, AuthN/AuthZ), code quality (hooks, race conditions, null safety, concurrent requests), and OneKey-specific patterns (Fabric crashes, MIUI, BigNumber). Triggers on "review PR", "review this PR", "code review", "check this diff", "审查 PR", "代码审查", "review
日本語の概要は準備中です。原文の説明を表示しています。
Evolve this harness with Darwin Mode — frozen model, evolving harness (real, sandboxed, safety-gated).
日本語の概要は準備中です。原文の説明を表示しています。
Select colormaps and qualitative palettes for scientific figures using perceptual-uniformity, color-vision-deficiency safety, and luminance-monotonicity criteria. Covers Crameri scientific colormaps, viridis/cividis/magma, Okabe-Ito categorical, ColorBrewer, and the rainbow/jet critique. Use when choosing palettes for heatmaps, scatter, networks, or any encoding where color carries quantitative or categorical meaning.
日本語の概要は準備中です。原文の説明を表示しています。
Prepares statistical reports for clinical trials following CONSORT 2025, SPIRIT 2025, ICH E9(R1) estimands, and FDA 2023 covariate adjustment guidance. Covers Table 1 generation, analysis populations (ITT/FAS/PP/Safety), the 5 ICH E9(R1) intercurrent-event strategies, MMRM under MAR (mmrm), reference-based MI (rbmi J2R/CR/CIR), Permutt tipping-point sensitivity, and Rubin's-rules vs frequentist variance debate. Use when preparing regulatory submissions, defining estimands, or implementing missing-data sensitivity analyses.
日本語の概要は準備中です。原文の説明を表示しています。
Predicts ADMET properties using ADMETlab 3.0 (119 endpoints with uncertainty), ADMET-AI, DeepChem MolNet, and chemprop D-MPNN with explicit handling of OECD QSAR principles, applicability domain assessment, calibration, hERG/CYP/AMES gold-standard endpoints, and PAINS / Lipinski / Ro5 / Veber / BBB druglikeness filters. Use when filtering compounds for drug-likeness, prioritizing leads by predicted safety, or building an in-house ADMET QSAR model.
日本語の概要は準備中です。原文の説明を表示しています。
Designs Bayesian clinical trials including Phase I dose-finding (BOIN, CRM, EWOC, mTPI-2), meta-analytic-predictive (MAP) priors with robust mixtures for external data borrowing, EXNEX for basket trials, hierarchical models for safety AE (Berry-Berry), Bayesian platform trials (I-SPY 2, GBM AGILE, REMAP-CAP), and posterior probability stopping rules. Covers FDA Bayesian Devices Guidance (2010), FDA Bayesian Methodology in Drugs Draft (January 2026), BOIN Fit-for-Purpose qualification (December 2021), and Project Optimus dose-optimisation. Use when designing dose-finding studies, platform trials, or sensitivity analyses with informative priors.
日本語の概要は準備中です。原文の説明を表示しています。
Advise on defensive security for industrial control systems you operate. Safety first. No process-disruption guidance.
日本語の概要は準備中です。原文の説明を表示しています。